Evidence map›Paper›PMID 37399286›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2024

Intronic

David Pellerin, Carlo Wilke, Andreas Traschütz, Sara Nagy, Riccardo Currò, Marie-Josée Dicaire, Hector Garcia-Moreno, Mathieu Anheim, Thomas Wirth, Jennifer Faber and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. TheBrain communications · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 8 countries.

David Pellerin *Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK matthis.synofzik@uni-tuebingen.de david.pellerin.21@ucl.ac.uk.ORCID 0000-0002-5807-995X
Carlo Wilke *Research Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-7250-8597
Andreas TraschützResearch Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
Sara NagyDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.
Riccardo CurròDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.
Marie-Josée DicaireDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC, Canada.
Hector Garcia-MorenoAtaxia Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Mathieu AnheimService de Neurologie, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg, France.
Thomas WirthService de Neurologie, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg, France.
Jennifer FaberDepartment of Neurology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0003-3265-0262
Dagmar TimmannDepartment of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
Christel DepienneInstitute of Human Genetics, Essen University Hospital, University of Duisburg-Essen, Essen, Germany.
Dan RujescuDepartment of Psychiatry and Psychotherapy, Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
José GazullaDepartment of Neurology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
Mary M ReillyDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.ORCID 0000-0003-0686-905X
Paola GiuntiAtaxia Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC, Canada.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.ORCID 0000-0002-2866-7777
Ludger SchölsGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Michael StruppDepartment of Neurology and German Center for Vertigo and Balance Disorders, LMU University Hospital, LMU Munich, Munich, Germany.
Andrea CorteseDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.ORCID 0000-0002-2208-5311
Matthis SynofzikResearch Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany matthis.synofzik@uni-tuebingen.de david.pellerin.21@ucl.ac.uk.ORCID 0000-0002-2280-7273
German Center for Neurodegenerative Diseases · DEMontreal Neurological Institute and Hospital · CAEssen University Hospital · DEHôpitaux Universitaires de Strasbourg · FRNational Hospital for Neurology and Neurosurgery · GBUniversity College London Hospitals NHS Foundation Trust · GBUniversity of Pavia · ITGerman Center for Lung Research · DEHospital Universitario Miguel Servet · ESMedical University of Vienna · ATUniversity Hospital Bonn · DEUniversity of Basel · CH

Funding

Medical Research Council MR/N028767/1Medical Research Council MR/S01165X/1Medical Research Council MR/T001712/1Wellcome Trust
6 · The paper itself

Abstract

backgroundIntronic GAA repeat expansions in the fibroblast growth factor 14 gene (

methodsWe recruited 45 patients negative for biallelic

resultsFrequency of

conclusionsGAA-

Indexed as

Bilateral VestibulopathyCerebellar AtaxiaPeripheral Nervous System DiseasesPolyneuropathiesVestibular DiseasesAtaxiaFibroblast Growth FactorsHumansSyndromefibroblast growth factor 14Fibroblast Growth FactorsCEREBELLAR ATAXIAMOVEMENT DISORDERSNEUROGENETICSNEUROPATHYVERTIGO

Identifiers

PMID37399286
PMCPMC10850669
OpenAlexW4382658132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.